Goldman Sachs Starts TherapeuticsMD (TXMD) at Buy
Get Alerts TXMD Hot Sheet
Price: $2.26 +0.44%
Rating Summary:
10 Buy, 4 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 10 | New: 10
Rating Summary:
10 Buy, 4 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 10 | New: 10
Join SI Premium – FREE
Goldman Sachs initiated coverage on TherapeuticsMD (NYSE: TXMD) with a Buy rating and a price target of $10.00.
For an analyst ratings summary and ratings history on TherapeuticsMD click here. For more ratings news on TherapeuticsMD click here.
Shares of TherapeuticsMD closed at $6.62 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- TD Cowen Starts Grindr (GRND) at Buy
- DA Davidson Starts Progress Software (PRGS) at Buy
- RBC Capital Starts Jasper Therapeutics (JSPR) at Outperform
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageRelated Entities
Goldman SachsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!